| Description | 1
Day Price Change %  | Market Cap | P/E | ROE
% | Div. Yield % | Long-Term
Debt to Equity | Price to Book
Value | Net Profit
Margin % (mrq) | Price to Free
Cash Flow (mrq) |
|---|
| Sector: Healthcare | 0.64 | 1947.8B | 55.20 | 12.57 | 2.58 | NA | 7.98 | 12.46 | 67.78 |
| Industry:
Drug Manufacturers - Major (More
Info) | 0.32 | 978.4B | 16.40 | 17.30 | 3.64 | NA | 8.24 | 18.40 | 86.70 |
| Companies |
| Abbott
Laboratories (ABT) | 2.09 | 83.9B | 14.70 | 27.52 | 3.00 | NA | 3.93 | 19.07 | 43.95 |
| Omeros
Corporation (OMER) | 1.42 | 21.1M | NA | NA | NA | NA | NA | NA | -6.64 |
| Eli
Lilly & Co. (LLY) | 1.36 | 42.9B | NA | -1.83 | 5.30 | NA | 4.33 | 16.93 | 207.17 |
| Avigen
Inc. (AVGN) | 1.33 | 45.4M | NA | -25.69 | NA | NA | 1.20 | NA | -19.55 |
| Evotec
AG (EVTC) | 1.31 | 673.7M | NA | -53.24 | NA | NA | NA | -35.16 | NA |
| WuXi
PharmaTech (Cayman) Inc. (WX) | 1.18 | 1.1B | NA | -2.83 | NA | NA | 4.01 | 20.45 | NA |
| AP
Pharma Inc. (APPA) | 1.08 | 29.5M | NA | -182.47 | NA | NA | 21.36 | NA | -11.12 |
| Novartis
AG (NVS) | 1.00 | 125.6B | 16.56 | 14.59 | 3.10 | NA | 2.36 | 18.58 | 55.58 |
| Keryx
Biopharmaceuticals Inc. (KERX) | 0.87 | 129.3M | 9.75 | 64.26 | NA | NA | 3.69 | NA | -99.23 |
| Johnson
& Johnson (JNJ) | 0.78 | 174.3B | 13.80 | 26.58 | 3.10 | NA | 3.46 | 22.18 | 47.14 |
| Aceto
Corp. (ACET) | 0.57 | 130.6M | 25.96 | 3.55 | 3.80 | NA | 0.90 | 1.42 | -16.23 |
| Bristol-Myers
Squibb Co. (BMY) | 0.44 | 49.8B | 13.02 | 27.57 | 5.00 | NA | 3.43 | 17.61 | 39.97 |
| Novogen
Limited (NVGN) | 0.41 | 50.2M | NA | -69.63 | NA | NA | 2.30 | -208.88 | -14.41 |
| GlaxoSmithKline
plc (GSK) | 0.33 | 107.2B | 13.30 | 58.25 | 4.70 | NA | 6.94 | 19.75 | 36.10 |
| Sanofi-Aventis
(SNY) | 0.03 | 100.9B | NA | NA | 3.70 | NA | NA | 28.68 | NA |
| Znomics,
Inc. (ZNOM.OB) | 0.00 | 0.6M | NA | -260.11 | NA | NA | 3.33 | -185.00 | -1.83 |
| Winston
Pharmaceuticals, Inc. (WPHM.OB) | 0.00 | 48.0M | NA | -129.03 | NA | NA | 47.69 | -200.42 | -81.06 |
| Vertical
Health Solutions Inc. (VHSL.OB) | 0.00 | 0.9M | NA | NA | NA | NA | NA | NA | -423.37 |
| Tetragenex
Pharmaceuticals, In (TTRX.OB) | 0.00 | 0.8M | NA | NA | NA | NA | NA | NA | 3.06 |
| Quick-Med
Technologies Inc. (QMDT.OB) | 0.00 | 20.3M | NA | NA | NA | NA | NA | NA | -50.54 |
| Neurologix
Inc. (NRGX.OB) | 0.00 | 16.7M | NA | -83.57 | NA | NA | 2.08 | NA | -8.15 |
| Javelin
Pharmaceuticals, Inc. (JAV) | 0.00 | 93.2M | NA | -317.53 | NA | NA | NA | NA | -29.43 |
| iBio,
Inc. (IBPM.OB) | 0.00 | 26.3M | NA | NA | NA | NA | 5.00 | NA | -127.68 |
| Callisto
Pharmaceuticals, Inc. (CLSP.OB) | 0.00 | 12.7M | NA | NA | NA | NA | NA | NA | -17.71 |
| AstraZeneca
plc (AZN) | -0.33 | 65.6B | 9.09 | 40.66 | 2.60 | NA | 3.38 | 25.79 | 40.57 |
| Spectrum
Pharmaceuticals, Inc. (SPPI) | -0.42 | 228.9M | NA | -30.57 | NA | NA | 1.84 | -118.14 | 418.11 |
| Merck
& Co. Inc. (MRK) | -0.55 | 76.4B | 9.51 | 37.90 | 4.20 | NA | 3.33 | 56.60 | 18.22 |
| Rigel
Pharmaceuticals, Inc. (RIGL) | -0.62 | 414.6M | NA | -91.80 | NA | NA | 3.18 | NA | -26.00 |
| Impax
Laboratories Inc. (IPXL) | -0.79 | 702.3M | 29.18 | 14.25 | NA | NA | 3.87 | 10.29 | 37.76 |
| Myriad
Pharmaceuticals, Inc. (MYRX) | -0.93 | 129.9M | NA | -76.32 | NA | NA | 0.72 | NA | -24.20 |
| Pfizer
Inc. (PFE) | -1.19 | 147.8B | 15.21 | 12.12 | 3.50 | NA | 2.24 | 24.77 | 59.05 |
| Provectus
Pharmaceuticals, Inc (PVCT.OB) | -2.94 | 64.3M | NA | -110.12 | NA | NA | 6.35 | NA | -36.55 |
| Skystar
Bio Pharmaceutical Com (SKBID) | -3.08 | 81.0M | 6.74 | 20.91 | NA | NA | 1.59 | 41.85 | -15.14 |
| CPEX
Pharmaceuticals, Inc. (CPEX) | -4.76 | 28.0M | NA | -9.94 | NA | NA | 1.21 | -17.61 | -21.29 |
| China
Aoxing Pharmaceutical Co (CAXG.OB) | -5.00 | 104.5M | NA | -10.83 | NA | NA | 3.84 | -77.00 | -38.74 |
| GeoPharma
Inc. (GORX) | -9.84 | 10.6M | NA | -53.74 | NA | NA | 1.60 | -73.18 | 3.89 |
| Medizone
International Inc. (MZEI.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| HST
Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| China
Pharma Holdings, Inc. (CPHI) | NA | NA | NA | 27.37 | NA | NA | NA | 46.15 | NA |